Camptothecin (Cpt), CAS# 2114454, is a Plant extracts manufactured through plant extraction, available as Light Yellow powder. Camptothecin (Cpt) is widely used as nutrition supplements. It is widely accepted as safe food additive in many countries.
No significant side effects reported.
As Camptothecin (CPT) Side Effects is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Camptothecin (CPT) Side Effects for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Camptothecin (CPT) Side Effects could have any negative effects on these vulnerable groups. It should be safe to use Camptothecin (CPT) Side Effects in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Camptothecin (CPT) Side Effects for long period in food for newborns or pregnant.
Though Camptothecin (CPT) Side Effects is not on FDA's GRAS exemption list, it's still widely accepted as safe food additive in many countries including USA with specific limit on dosage.
No health issues about Camptothecin (CPT) Side Effects reported up to now.
1. Thermosensitive mPEG-b-PA-g-PNIPAM comb block copolymer micelles: effect of hydrophilic chain length and camptothecin release behavior. [Pharm Res. 2014 Feb]
Author: Yang XL, Luo YL, Xu F, Chen YS.
2. Nano scale self-emulsifying oil based carrier system for improved oral bioavailability ofcamptothecin derivative by P-Glycoprotein modulation. [Colloids Surf B Biointerfaces. 2013 Nov 1]
Author: Negi LM, Tariq M, Talegaonkar S.
3. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecinanalog for oral administration. [Curr Drug Deliv. 2011 Nov]
Author: Nekkanti V, Venkateswarlu V, Ansari KA, Pillai R.
4. Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment withcamptothecin-loaded PLGA nanoparticles. [Drug Deliv Transl Res. 2011 Oct 1]
Author: Blum JS, Weller CE, Booth CJ, Babar IA, Liang X, Slack FJ, Saltzman WM.